Daxor Corporation Announces Hiring of Chief Financial Officer
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 06/17/16 -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces the hiring of Eric P. Coleman as its new Chief Financial Officer effective June 6, 2016, reporting directly to Michael Feldschuh, Acting President & CEO of Daxor Corporation. "Mr. Coleman will be responsible for overseeing the financial activities of Daxor and will help lead in the ongoing restructuring of the company as well as negotiating joint ventures and corporate actions to enhance shareholder value in a transformative way," said Mr. Feldschuh.
Eric is a licensed CPA and has more than 25 years of finance leadership experience, including tenures with high-profile international public companies. His experience spans financial management and risk management in the technology sectors complemented by several years in the manufacturing and medical device industries. He is passionate about improving processes to increase market value and possesses a deep understanding of accounting, tax, payroll, and finance, in both large and small enterprises. His knowledge of international settings and cultures gives him unique insight in working with diverse groups to create effective, seamless, and high performing teams. He received his Bachelor''s Degree in Accounting from Xavier University.
Mr. Coleman stated, "I am thrilled to join Daxor. The strategic growth opportunities for the company are compelling, and the mission of saving lives has never been more important. Daxor''s BVA-100 Blood Volume Analyzer is a lifesaving diagnostic used at leading hospitals in the country. I look forward to being an integral part of the team at Daxor and helping to drive further success for the company."
Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex, Daxor''s single use diagnostic kit. For more information regarding Daxor Corporation''s Blood Volume Analyzer BVA-100, visit Daxor''s website at .
Daxor Contact Information:
Lisa Quartley
Senior Vice President, Marketing and Commercial Development
212-330-8518
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.06.2016 - 07:00 Uhr
Sprache: Deutsch
News-ID 1442179
Anzahl Zeichen: 4244
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Dentistry
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 283 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Daxor Corporation Announces Hiring of Chief Financial Officer
"
steht unter der journalistisch-redaktionellen Verantwortung von
Daxor Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
